Revolutionizing Drug Delivery: Nicardipine Nanosuspension Formulation and In-Vitro Evaluation
Abstract
Nicardipine hydrochloride, is a potent calcium channel blocker, is commonly used in the management of hypertension and angina. It is a BCS class II drug which has low aqueous solubility and high permeability. In the present study, an attempt was made to formulate and evaluate nanosuspension of Nicardipine hydrochloride using different stabilizers, namely Tween 80, PVP K30, Poloxamer 188 by using Nanoprecipitation method with the objective to improve solubility and enhance dissolution of Nicardipine hydrochloride. Prepared nanosuspensions were evaluated for drug-excipient compatibility, particle size, PDI (Polydispersity Index), Zeta potential, Drug content, Saturation solubility, In-vitro release study, Scanning electron microscopy (SEM). FTIR (Fourier Transform Infrared Spectroscopy) studies revealed the compatibility of the drug with excipients. Nanosuspension (F3), which had the lowest particle size and the highest % Drug Release, was selected as the optimum formulation. It showed the droplet size, PDI, ZP,% Drug content and %Drug release of 150.4 nm,0.243, -30.6 mV,95.52%,91.24%. Kinetic release profiles of the NS F3 revealed that it followed First order kinetics. This study showed the ability of nanosuspension system in improving the solubility and drug release of Nicardipine.
Keywords: Nicardipine, Nanosuspension, Solubility, % Drug Release, % Drug content, Scanning electron microscopy.
Keywords:
Nicardipine, Nanosuspension, Solubility, % Drug Release, % Drug content, Scanning electron microscopyDOI
https://doi.org/10.22270/jddt.v13i12.6134References
Kawabata Y, Kwada K, Nakatani M, SYamada S, Onoue S, Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications, Int. J. Pharm, 2011;420(1): 1-10. https://doi.org/10.1016/j.ijpharm.2011.08.032 PMid:21884771
Kumar S, Singh P, Various techniques for solubility enhancement: an overview, Pharma Innov. J, 2016; 5(1):23-28.
Wang Y, Zheng Y, Zhang L, Wang Q, Zhang D,Stability of nanosuspensions in drug delivery, J Control Release, 2013;172(3):1126-41. https://doi.org/10.1016/j.jconrel.2013.08.006 PMid:23954372
Shen C, Shen B, Liu X, Yuan H, Nanosuspensions based gel as delivery system of nitrofurazone for enhanced dermal bioavailability, J. Drug Deliv. Sci. Technol, 2018;43: 1-11. https://doi.org/10.1016/j.jddst.2017.09.012
Jane M, Agrawal S, Khan A, Formulation And Evaluation Of Nanosuspension Of Valsartan, Int J Curr Pharm Res, 2018;10(2):68-74. https://doi.org/10.22159/ijcpr.2018v10i2.25874
Bhalekar R. Mangesh, Madgulkar R. Ashwini, Shaikh G.Shagufta, Formulation and Evaluation of Chitosan- Based Mucoadhesive Buccal Patch of prochlorperazine Maleate, An International Journal of Pharmacy and Pharmaceutical Research, 2018;12(4):61-73.
Vinod K.R, Santhosha D, Anbazhagan. S, Formulation And Evaluation of Piperine Cream a New Herbal Dimensional Approach For Vitiligo Patients, International Journal Of Pharmacy And Pharmaceutical Sciences, 2011;3(2):29-33.
Pandey N, Dr. Sah AN, Mahara K, Formulation and evaluation of floating microspheres of nateglinide, Int J Pharm Sci Res, 2016;7:453-464.
Jassem NA, Rajab NA, Formulation and in vitro evaluation of azilsartan medoxomil nanosuspension, Int J Pharm Pharm Sci, 2017;9(7):110-119. https://doi.org/10.22159/ijpps.2017v9i7.18917
Sumathi R, Tamizharasi S, Sivakumar T, Formulation and evaluation of polymeric nanosuspension of naringenin, Int J Appl Pharm, 2017;9(6):60-70. https://doi.org/10.22159/ijap.2017v9i6.21674
Anjane M, Agrawal S, Khan A, Formulation and evaluation of nanosuspension of Valsartan, Int J Curr Pharm Res, 2018;10(2):68-74. https://doi.org/10.22159/ijcpr.2018v10i2.25874
Karakucuk A, Celebi N, Teksin ZS, Preparation of ritonavir nanosuspensions by microfluidization using polymeric stabilizers: I. A Design of Experiment approach, Eur J Pharm Sci, 2016;95:111-121. https://doi.org/10.1016/j.ejps.2016.05.010 PMid:27181836
Jawahar, N. & S.N, Meyyanathan & Senthil, Vel & Kuppusamy, Gowthamarajan & Elango, K, Studies on physico-chemical and pharmacokinetic properties of olanzapine through nanosuspension, Journal of Pharmaceutical Sciences and Research, 2013;5(10):196-202.
Patel DJ, Pandya VM, Patel JK, International Journal of Pharmaceutical Research, 2009;5(2):3318-3324.
Liu D, Pan H, He F, Wang X, Li J, Yang X, Effect of particle size on oral absorption of carvedilol nanosuspensions: In vitro and in vivo evaluation, Int J Nanomedicine, 2015;10:6425-6434. https://doi.org/10.2147/IJN.S87143 PMid:26508852 PMCid:PMC4610768
Yuancai D, Wai KN, Jun H, Shoucang S, Reginald BHT, A continuous and highly effective static mixing process for antisolvent precipitation of nanoparticles of poorly water-soluble drugs, Int J Pharm, 2010; 386(1-2):256-261 https://doi.org/10.1016/j.ijpharm.2009.11.007 PMid:19922777
Patravale V.B, Date A.A, Kulkarni R.M. Nanosuspensions: A Promising Drug Delivery Strategy, Journal of Pharmacy Pharmacology, 2004;56(7): 827-840. https://doi.org/10.1211/0022357023691 PMid:15233860
Vyas Himanshu D, Parmar Ghanshyam, Shah Nirmal, Chauhan Sachin, Seth A K, Formulation and evaluation of fast dissolving film of methylcobalamin, An International Journal of Pharmaceutical Sciences, 2015;6(4):50-68.
Murthy KVR, Raju V, Development and validation of new discriminative dissolution method for carvedilol tablets, Indian J Pharm Sci, 2011;73(5):527-536. https://doi.org/10.4103/0250-474X.99000 PMid:22923865 PMCid:PMC3425064
Bajaj A, Rao MRP, Pardeshi A, Sali D, Nanocrystallization by evaporative antisolvent technique for solubility and bioavailability enhancement of telmisartan, AAPS Pharm SciTech, 2012;13(4): 1331-1340. https://doi.org/10.1208/s12249-012-9860-x PMid:23054986 PMCid:PMC3513472
Yasemin, Budama-Kilinc, Piperine Nanoparticles for Topical Application:Preparation, Characterization, In vitro and In silico Evaluation,Chemistry Select, 2019;4(40):11693- 11700. https://doi.org/10.1002/slct.201903266
Vijay Agarwal1,and Meenakshi Bajpai, Preparation and Optimization of Esomeprazole Nanosuspension using Evaporative Precipitation-Ultrasonication, Tropical Journal of Pharmaceutical Research, 2014;13(4):497-503. https://doi.org/10.4314/tjpr.v13i4.2
Dolenc A, Govedarica B, Kocbek P, Srčič S, Kristl J, Nanosized particles of orlistat with enhanced in vitro dissolution rate and lipase inhibition, International journal of pharmaceutics, 2010;396(1-2):149-155. https://doi.org/10.1016/j.ijpharm.2010.06.003 PMid:20540997
Published
Abstract Display: 730 
PDF Downloads: 725 PDF Downloads: 169 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.